|
|
Abbott Laboratories CDR
TSX •
Healthcare •
Medical Devices •
Quote as of 10/30/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeTSX
Market Capitalization247,958 mln
Float11,897 mln
Earnings Date10/21/2026
Relative Strength
78
/ 100
Strongly outperforming
Key Fundamentals
EPS0.46
P/E40.26
ROE9.15
RPS38.77
ROIC6.50
ROA4.95
Interest Cover8.07
EBITDA, mln13,983
EV / EBITDA20.45
EV / EBIT27.76
Revenue, mln66,943
EV / Revenue4.28
Quote Details
Last
18.52
Change
0.32 (1.76%)
Open
18.64
Volume
11,727
Turnover
217,184
Average Volume
14,768
Financial Ratios
Pre-Tax Profit Margin14
Leverage Ratio2.14
Current Ratio1.38
Price / Book3.47
Price / Cash Flow18.64
Price / Free Cash Flow22.89
Debt / Equity0.64
Price / Sales3.71
PEG Ratio10.65
Financial Strength
Altman Z-Score3.24
Piotroski F-Score
5
/ 9
Beneish M-Score-2.69
Price to Intrinsic Value1.67
Shiller PE Ratio29.76
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
2.32% |
89
/ 100
 |
| 1 Month |
7.69% |
89
/ 100
|
| 2 Months |
5.44% |
79
/ 100
 |
| 6 Months |
17.27% |
87
/ 100
|
|
| |
